RPL17P49

Across TCGA pan-cancer cohorts, RPL17P49 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RPL17P49 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RPL17P49 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL17P49 expression acts as an unfavorable survival marker, although some lineages such as LUSC show a favorable association.

KIRC, COAD, and CESC are the cancer types where RPL17P49 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	II,III,IV	0.334	0.710	<.001	180	view →
COAD	OS	Tertile	III,IV	0.127	0.703	<.001	72	view →
CESC	DFS	Tertile	III,IV	0.190	0.727	.006	54	view →
READ	OS	Tertile	II,III,IV	0.056	0.934	<.001	36	view →
STAD	OS	Tertile	IV	0.099	0.564	.006	30	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	27	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
SARC	OS	Tertile	All	0.326	0.736	.020	9	view →
PCPG	DFS	Tertile	All	0.063	0.921	<.001	9	view →
LUSC	DFS	Tertile	III,IV	1.000	0.269	.033	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RPL17P49–KIRC (OS)

Open the KIRC breakdown →